Furthermore, steatosis was reduced by OCA or GW4064.(24) Therefore, the inhibitory effects of FXR-ligands on the hepatic steatosis in animal models are associated with decreased lipogenesis through the FXR-SHP-SREBP-1c cascade. The gene discussed is SREBF1; the disease is fatty liver disease.